Viewing Study NCT04053634


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2025-12-29 @ 9:02 AM
Study NCT ID: NCT04053634
Status: COMPLETED
Last Update Posted: 2025-08-19
First Post: 2019-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Obstructive Pulmonary Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Obstructive Pulmonary Disease View
None COPD View
None benralizumab View
None Fasenra View
None ICS View
None inhaled corticosteroids View
None exacerbations View
None Lung Disease View
None LABA/LAMA View